Why the study?
Three current methods for determining creatine kinase-MB activity were evaluated due to differences in precision, sensitivity, and specificity among them.
Observational (n=80)
No
Three current methods for the determination of the creatine kinase-MB activity were evaluated: electrophoresis (Beckman Inst.), ion-exchange MB-Zyme (J.T. Baker) and ion-exchange on aca (Du Pont). Eighty patients were selected out of three groups: acute myocardial infarction, heart and vascular surgery patients and a number of noncardiac cases. The precision of the ion-exchange methods was comparable; CV 5.7% (aca) and CV 5.2% (MB-Zyme) for a high creatine kinase-MB pool. Electrophoresis overestimated the creatine/kinase-MB/activity and was less precise (CV 9.6%) and less sensitive than the ion-exchange methods. The aca (Du Pont) method was less specific than the MB-Zyme. The main source of discrepancy was samples from certain patients in the surgery unit, which gave falsely high value by the aca method, and showed altered mobility in electrophoresis, suggesting an atypical creatine kinase. Three macro creatine kinase type I included in this study were erroneously determined as creatine kinase-MB by both the ion-exchange methods.
No takes yet. Share an insight, caveat, or question.
Spincemaille et al. (1984) conducted an observational in Acute myocardial infarction (n=80). Creatine kinase-MB catalytic activity determination methods (aca Du Pont, MB-Zyme, Electrophoresis) vs. Clinical diagnosis by a cardiology team was evaluated on Diagnostic sensitivity, specificity, and precision for detecting acute myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: